Skip to main content
. 2004 Jan 20;90(2):353–358. doi: 10.1038/sj.bjc.6601472

Figure 2.

Figure 2

OS curves for patients grouped according to the AUCMTX. Patients treated with an AUCMTX >1100 μmol h  l−1 (continued line) showed a significantly better survival with respect to those treated with an AUCMTX ⩽1100 μmol h  l−1 (dotted line).